Accelerating statistical research in drug safety.

نویسندگان

  • Warren Bilker
  • Victor Gogolak
  • David Goldsmith
  • Manfred Hauben
  • Guillermo Herrera
  • Alan Hochberg
  • Steve Jolley
  • Martin Kulldorff
  • David Madigan
  • Robert Nelson
  • Alan Shapiro
  • Galit Shmueli
چکیده

While discussions continue about the precise role of data mining in drug safety, there can be little doubt that data mining algorithms have established themselves as a component of the pharmacovigilance “tool-kit”. The drug safety community should facilitate research into the development and testing of novel data mining and statistical algorithms that match the importance and complexity of the pharmacovigilance challenge. Nonetheless, significant barriers currently exist that impede the progress of research and development in this area. Below we identify these barriers and suggest a course of action.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

COMPARISON OF EVALUATION OF PATIENT SAFETY ASSESSMENT INDICATORS IN SPECIAL SECTIONS HOSPITALS PRIVATE AND EDUCATIONAL AHVAZ UNIVERSITY OF MEDICAL SCIENCES IN 2019

Background & Aims: One of the most important issues in the health care system is the observance of patient safety indicators, especially in special sections. In this regard, the evaluation of patient safety assessment in Special care wards as an issue It is always important. Objective: The aim of this study was to evaluate the evaluation of patient safety assessment indicators in the special wa...

متن کامل

Computational tools and interdisciplinary ingenuity for accelerating the development of new medicine

The rising costs of research and development, coupled with the low probability of reaching approval, have resulted in many big pharma’s being risk adverse and less likely to pursue novel targets. Research and development to point of marketing costs have been increasing at an annual rate of 8.5% above inflation [3]. On the order of 90% of the compounds entering clinical trials do not meet the re...

متن کامل

رابطه استقرار ایمنی بیمار با نوع خطای دارویی گزارش شده در یک بیمارستان دولتی شهر تهران

Background and Aim: Medication is a very important part of care and therapeutic services in health service delivery units. Therefore, medication errors in hospitals may cause serious problems in patient care and, even, death. This study aimed to determine the relationship between the type of medication errors reported and patient safety standards in a public hospital in Tehran, Iran. Materials...

متن کامل

AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development.

Recent discoveries in cancer biology have greatly increased our understanding of cancer at the molecular and cellular level, but translating this knowledge into safe and effective therapies for cancer patients has proved to be challenging. There is a growing imperative to modernize the drug development process by incorporating new techniques that can predict the safety and effectiveness of new ...

متن کامل

Biomarkers in Pharmaceutical Research.

BACKGROUND Biomarkers are important tools in drug development and are used throughout pharmaceutical research. CONTENT This review focuses on molecular biomarkers in drug development. It contains sections on how biomarkers are used to assess target engagement, pharmacodynamics, safety, and proof-of-concept. It also covers the use of biomarkers as surrogate end points and patient selection/com...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Pharmacoepidemiology and drug safety

دوره 15 9  شماره 

صفحات  -

تاریخ انتشار 2006